Skip to search formSkip to main contentSkip to account menu

Integrase Inhibitors

Known as: Inhibitors, Integrase, integrase inhibitor 
Compounds which inhibit or antagonize biosynthesis or actions of integrase.
National Institutes of Health

Related topics

Related topics

4 relations
In Bloodaspects of radiation effectschemical synthesisstandards characteristics

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
Advancing the portfolio of tuberculosis diagnostics, drugs, biomarkers, and vaccines.
Review
2010
Review
2010
GSK-1349572, a novel integrase inhibitor for the treatment of HIV infection.
GSK-1349572 (S/GSK-1349572), under development by ViiV Healthcare and Shionogi & Co Ltd, is the lead from a series of HIV… 
Highly Cited
2009
Highly Cited
2009
Elvitegravir, an oral HIV integrase inhibitor, for the potential treatment of HIV infection.
The treatment of HIV is often complicated by the emergence of antiretroviral (ARV) resistance, which has prompted the development… 
2009
2009
Catalytic asymmetric synthesis of an HIV integrase inhibitor.
An efficient synthesis of HIV integrase inhibitor (S)-(-)-1 via a unique asymmetric hydrogenation of a mixture of imines/enamine… 
Review
2008
Review
2008
Integrase inhibitors for the treatment of HIV infection.
HIV-1 integrase catalyzes the insertion of HIV-1 DNA into the genome of the host cell and, therefore, represents a rational… 
Review
2007
Review
2007
Design of second generation HIV-1 integrase inhibitors.
The prospect of HIV-1 integrase (IN) as a therapeutically viable retroviral drug target is on the verge of realization. The… 
2006
2006
Binding mode prediction of strand transfer HIV-1 integrase inhibitors using Tn5 transposase as a plausible surrogate model for HIV-1 integrase.
The crystal structure of Tn5 transposase-DNA complex was used in docking experiments to predict binding modes of HIV-1 integrase… 
2001
2001
Arylisothiocyanate-containing esters of caffeic acid designed as affinity ligands for HIV-1 integrase.
2001
2001
Synthesis and HIV-1 integrase inhibitory activities of catechol and bis-catechol derivatives.
1997
1997
Hydrazide-containing inhibitors of HIV-1 integrase.
Inhibitors of HIV integrase are currently being sought as potential new therapeutics for the treatment of AIDS. A large number of… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)